huCART-meso
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for huCART-meso, covering 2025-06-25 to 2025-06-25. Get the full timeline:
Most recent: Clinical Trial Update: huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer [Phase 1]